Neuland Share price Target 2025, 2026, 2027 to 2030

Do you want to know the Neuland share price target for the year 2025? Here, you will get a detailed analysis of the company’s financial performance, historical data, and price target for the year 2025, 2026, 2027, 2028, 2029, and 2030 provided by the market experts and analysts.

About Neuland Laboratories Ltd

Neuland Laboratories is a company in India that makes the important building blocks used to make medicines. Instead of making finished medicines, the company produces special ingredients called APIs that help drugs work properly. These ingredients are used by many different medicine makers all around the world. Neuland has a team of scientists who carefully check each product to make sure it is safe and of high quality.

Neuland Fundamentals

• Market Cap: ₹18,167.12Cr.
• P/E Ratio: 70.03
• Book Value: ₹1,182.30
• Dividend Yield: 0.08%
• ROE: 18.58%
• ROCE: 23.49%
• 52-Week High: ₹18,089.55
• 52-Week Low: ₹7,900

Neuland Shareholding Pattern

• Promoter: 32.68%
• FII: 21.69%
• DII: 11.97%
• Public: 33.67%
• Others: 0%

Neuland Share Price Historical Data

Neuland Share Price Target 2025 to 2030

Year Wise Analysis

Neuland Laboratories is a well-known pharmaceutical company in India that makes and sells medicines and active pharmaceutical ingredients (APIs) used around the world. The company has built a good name for itself by focusing on quality and innovation.

Because of its growing business and demand for medicines, many investors believe Neuland could see strong growth in the future. Experts have shared their predictions for the company’s share price in the coming years. In 2025, Neuland’s share price is expected to be around ₹14,500. If the company continues to perform well, the price could rise to ₹17,000 in 2026. By 2027, it may go up to ₹19,200. In 2028, the share price might reach ₹21,200. In 2029, experts predict it could increase to ₹22,850.

Looking further ahead, by 2030, the price may touch ₹24,000. These numbers show a positive outlook for the company. The real share prices can go up or down depending on the company’s performance and changes in the market. That’s why it’s always wise to research well and invest carefully.

Also Read: Network 18 Share Price Target 2025, 2026, 2027 to 2030

Neuland Peer Companies

The peer companies of Neuland which are in tough competition are Sun Pharmaceutical Industries, Divi’s Laboratories, Cipla, Torrent Pharmaceuticals, Dr. Reddy’s Laboratories, Mankind Pharma, Concord Biotech, Blue Jet Healthcare, Gufic Biosciences, Alivus Life Sciences, Natco Pharma, and Sai Life Sciences.

F&Q

Rishi Gupta